JPM26: Insulet presents optimistic growth plan heading into 2026 [Yahoo! Finance]
Insulet Corporation (PODD)
Last insulet corporation earnings: 2/25 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.insulet.com/investor-relations
Company Research
Source: Yahoo! Finance
rate (CAGR) of 25% between 2021-2025, with 2025 revenue coming to approximately $2.7bn. Insulet also claimed to have driven 66% of the growth of the automated insulin delivery (AID) market during the last five years. These sales are wholly attributed to Insulet's flagship product, the Omnipod 5, the first AID system FDA-cleared for type 1 and type 2 diabetes in the US. Insulet estimates their current total addressable market (TAM) for AID to be approximately 8 million people with diabetes, which translates to roughly $6bn in total market value and is anticipated to grow to $9bn by 2028. A growth plan is in place to develop new markets such as type 1 diabetes outside of the US, type 2 diabetes for basal-only treatment in the US as well as expanding coverage of type 1 diabetes in Asia, aiming to increase the TAM to approximately 17 million people with diabetes. Insulet's innovation roadmap includes enhancements to the Omnipod 5 ecosystem involving algorithm improvements, simplified
Show less
Read more
Impact Snapshot
Event Time:
PODD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PODD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PODD alerts
High impacting Insulet Corporation news events
Weekly update
A roundup of the hottest topics
PODD
News
- Bernstein Reduces Firm's PT on Insulet (PODD) Stock [Yahoo! Finance]Yahoo! Finance
- Insulet (NASDAQ:PODD) was downgraded by analysts at Barclays PLC from an "overweight" rating to an "equal weight" rating. They now have a $274.00 price target on the stock.MarketBeat
- Why Analysts See The Insulet (PODD) Story Shifting As Omnipod Growth Meets Valuation Questions [Yahoo! Finance]Yahoo! Finance
- Insulet to Announce Fourth Quarter and Full Year 2025 Financial Results on February 18, 2026 [Yahoo! Finance]Yahoo! Finance
- Insulet (NASDAQ:PODD) had its "outperform" rating reaffirmed by analysts at Sanford C. Bernstein.MarketBeat
PODD
Earnings
- 11/6/25 - Beat
PODD
Sec Filings
- 1/6/26 - Form 4
- 1/6/26 - Form 4
- 12/19/25 - Form 8-K
- PODD's page on the SEC website